Multimodality MRI and PET for restaging prostate cancer after biochemical failure of the treatment

被引：8

作者：

Cochet, A. ^{[1
,2
,3
]}

Kanoun, S. ^{[1
,2
]}

Humbert, O. ^{[1
,2
,3
]}

Walker, P. -M. ^{[2
,3
]}

Cormier, L. ^{[4
]}

Crehange, G. ^{[2
,5
]}

Brunotte, F. ^{[1
,2
,3
]}

机构：

[1] Ctr Georges Francois Leclerc, Nucl Med Serv, F-21079 Dijon, France

[2] Univ Bourgogne, UMR 6306, Lab Elect Informat & Image Le2i, F-21078 Dijon, France

[3] CHU Dijon, Serv Spect RMN, F-21079 Dijon, France

[4] CHU Dijon, Serv Urol, F-21079 Dijon, France

[5] Ctr Georges Francois Leclerc, Serv Radiotherapie, F-21079 Dijon, France

来源：

CANCER RADIOTHERAPIE | 2014年 / 18卷 / 5-6期

关键词：

Multimodality MRI; PET; Prostate cancer; Biochemical failure; POSITRON-EMISSION-TOMOGRAPHY; MULTIPARAMETRIC MAGNETIC-RESONANCE; RADICAL RETROPUBIC PROSTATECTOMY; EXTERNAL-BEAM RADIOTHERAPY; LYMPH-NODE METASTASES; CONTRAST-ENHANCED MRI; C-11-CHOLINE PET/CT; RADIATION-THERAPY; LOCAL RECURRENCE; F-18-CHOLINE PET/CT;

D O I：

10.1016/j.canrad.2014.07.148

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Major improvements in the field of radiotherapy planning such as stereotactic radiation therapy, have recently been performed, aiming to the development of personalized therapeutic strategies in patients with biochemical failure of prostate cancer. However, this needs an early and accurate location of sites of recurrence. Development of multimodality magnetic resonance imaging (MRI) and positron emission tomography (PET) permits to consider this objective. Thus, it is worthwhile to apprehend the respective performance of these imaging techniques in order to rationalize their use. We propose a review of the recent literature organized by technique and by location, regarding the performance of multimodality MRI and PET for restaging of patients with biochemical failure of prostate cancer initially treated with curative intent. (C) 2014 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.

引用

页码：509 / 516

页数：8

共 50 条

[41] Predicting Biochemical Failure in Irradiated Patients With Prostate Cancer by Tumour Volume Measured by Multiparametric MRI [J].

Oerther, Benedict ;

Buren, Moritz, V ;

Klein, Christina M. ;

Kirste, Simon ;

Nicolay, Nils H. ;

Sprave, Tanja ;

Spohn, Simon ;

Gunashekar, Deepa Darshini ;

Hagele, Leonard ;

Bielak, Lars ;

Bock, Michael ;

Grosu, Anca-L ;

Bamberg, Fabian ;

Benndorf, Matthias ;

Zamboglou, Constantinos .

IN VIVO, 2020, 34 (06) :3473-3481

[42] PET-CT for treatment planning in prostate cancer [J].

Picchio, M. ;

Crivellaro, C. ;

Giovacchini, G. ;

Gianolli, L. ;

Messa, C. .

QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 53 (02) :245-268

[43] Value of Targeted Biopsies and Combined PSMA PET/CT and mp-MRI Imaging in Locally Recurrent Prostate Cancer after Primary Radiotherapy [J].

Rasing, Marnix ;

van Son, Marieke ;

Moerland, Marinus ;

de Keizer, Bart ;

Wessels, Frank ;

Jonges, Trudy ;

van de Pol, Sandrine ;

Eppinga, Wietse ;

Noteboom, Juus ;

Lagendijk, Jan ;

van der Voort van Zijp, Jochem ;

Peters, Max .

CANCERS, 2022, 14 (03)

[44] Simultaneous whole-body PET/MRI with integrated multiparametric MRI for primary staging of high-risk prostate cancer [J].

Kaufmann, Sascha ;

Kruck, Stephan ;

Gatidis, Sergios ;

Hepp, Tobias ;

Thaiss, Wolfgang M. ;

Hennenlotter, Joerg ;

Schwenck, Johannes ;

Scharpf, Marcus ;

Nikolaou, Konstantin ;

Stenzl, Arnulf ;

Reischl, Gerald ;

la Fougere, Christian ;

Bedke, Jens .

WORLD JOURNAL OF UROLOGY, 2020, 38 (10) :2513-2521

[45] Restaging rectal cancer after neoadjuvant treatment with multiparametric MRI: A landscape of new opportunities [J].

Nougaret, S. ;

Rouanet, P. .

DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2016, 97 (09) :839-841

[46] Survival after biochemical failure in prostate cancer treated with radiotherapy: Spanish Registry of Prostate Cancer (RECAP) database outcomes [J].

C. González-San Segundo ;

J. Jové ;

A. Zapatero ;

J. Pastor-Peidro ;

M. L. Vázquez ;

M. Casaña ;

J. L. Mengual ;

A. Gómez-Caamaño ;

A. Gómez-Iturriaga ;

C. Vallejo ;

I. Henríquez ;

J. L. Muñoz-García ;

J. Clemente ;

M. Porras ;

E. Collado ;

G. Ossola ;

E. Villafranca ;

M. A. Cabeza ;

J. López-Torrecilla .

Clinical and Translational Oncology, 2019, 21 :1044-1051

[47] Comparison of restaging accuracy of repeat FDG-PET/CT with pelvic MRI after preoperative chemoradiation in patients with rectal cancer [J].

Huh, Jung Wook ;

Kwon, Seong Young ;

Lee, Jae Hyuk ;

Kim, Hyeong Rok .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (02) :353-359

[48] Salvage radiotherapy of recurrent prostate cancer after PSMA PET/MRI and PET/CT [J].

Knudtsen, Ingerid S. ;

Abrahamsen, Bendik S. ;

Selnaes, Kirsten M. ;

Langorgen, Sverre ;

Keil, Thomas M. ;

Johansen, Hakon ;

Castillejo, Miguel J. ;

Bogsrud, Trond V. ;

Aarsaether, Erling J. ;

Haugnes, Hege S. ;

Tandstad, Torgrim ;

Elschot, Mattijs ;

Bathen, Tone F. .

RADIOTHERAPY AND ONCOLOGY, 2024, 194 :S2391-S2393

[49] Sensitivity of PET/MRI to detect recurrence of prostate cancer [J].

Patricia Arce-Calisaya ;

Michael Souvatzoglou ;

Mathias Eiber ;

Ambros Beer ;

Klemens Scheidhauer ;

Hans Geinitz ;

Markus Schwaiger .

European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40 :799-799

[50] Recurrent prostate cancer: combined role for MRI and PSMA-PET in 68Ga-PSMA-11 PET/MRI [J].

Jannusch, Kai ;

Bruckmann, Nils Martin ;

Morawitz, Janna ;

Boschheidgen, Matthias ;

Quick, Harald H. ;

Herrmann, Ken ;

Fendler, Wolfgang P. ;

Umutlu, Lale ;

Stuschke, Martin ;

Hadaschik, Boris ;

Antoch, Gerald ;

Schimmoeller, Lars ;

Kirchner, Julian .

EUROPEAN RADIOLOGY, 2024, 34 (07) :4789-4800

← 1 2 3 4 5 →